These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 35099759)

  • 21. GSH-Depleted Nanozymes with Hyperthermia-Enhanced Dual Enzyme-Mimic Activities for Tumor Nanocatalytic Therapy.
    Dong S; Dong Y; Jia T; Liu S; Liu J; Yang D; He F; Gai S; Yang P; Lin J
    Adv Mater; 2020 Oct; 32(42):e2002439. PubMed ID: 32914495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transition-Metal-Oxide-Based Nanozymes for Antitumor Applications.
    Sun H; Bai Y; Zhao D; Wang J; Qiu L
    Materials (Basel); 2024 Jun; 17(12):. PubMed ID: 38930266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metal nanozymes modulation of reactive oxygen species as promising strategies for cancer therapy.
    Bu JW; Wang ZG; Liu HY; Liu SL
    Int J Pharm; 2024 Sep; 662():124453. PubMed ID: 39013531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydrogen Sulfide Gas Amplified ROS Cascade: FeS@GOx Hybrid Nanozyme Designed for Boosting Tumor Chemodynamic Immunotherapy.
    Sun W; Zhu C; Song J; Ji SC; Jiang BP; Liang H; Shen XC
    Adv Healthc Mater; 2023 Sep; 12(23):e2300385. PubMed ID: 37040018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Augmenting Immunotherapy via Bioinspired MOF-Based ROS Homeostasis Disruptor with Nanozyme-Cascade Reaction.
    Wang R; Qiu M; Zhang L; Sui M; Xiao L; Yu Q; Ye C; Chen S; Zhou X
    Adv Mater; 2023 Dec; 35(49):e2306748. PubMed ID: 37689996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Shape-Regulated Photothermal-Catalytic Tumor Therapy Using Polydopamine@Pt Nanozymes with the Elicitation of an Immune Response.
    Xu Z; Jiang J; Li Y; Hu T; Gu J; Zhang P; Fan L; Xi J; Han J; Guo R
    Small; 2024 May; 20(20):e2309096. PubMed ID: 38054612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Self-Adaptive Pyroptosis Inducer: Optimizing the Catalytic Microenvironment of Nanozymes by Membrane-Adhered Microbe Enables Potent Cancer Immunotherapy.
    Wang W; Zhang L; Zhang Y; Liu X; Song A; Ren J; Qu X
    Adv Mater; 2024 Apr; 36(14):e2310063. PubMed ID: 38153294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nitric oxide-mediated regulation of mitochondrial protective autophagy for enhanced chemodynamic therapy based on mesoporous Mo-doped Cu
    Zhou Z; Gao Z; Chen W; Wang X; Chen Z; Zheng Z; Chen Q; Tan M; Liu D; Zhang Y; Hou Z
    Acta Biomater; 2022 Oct; 151():600-612. PubMed ID: 35953045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor-Microenvironment-Responsive Cascade Reactions by a Cobalt-Single-Atom Nanozyme for Synergistic Nanocatalytic Chemotherapy.
    Cai S; Liu J; Ding J; Fu Z; Li H; Xiong Y; Lian Z; Yang R; Chen C
    Angew Chem Int Ed Engl; 2022 Nov; 61(48):e202204502. PubMed ID: 35972794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Smart Nanozymes for Cancer Therapy: The Next Frontier in Oncology.
    P N N; Mehla S; Begum A; Chaturvedi HK; Ojha R; Hartinger C; Plebanski M; Bhargava SK
    Adv Healthc Mater; 2023 Oct; 12(25):e2300768. PubMed ID: 37392379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Advances in the Application of Nanozymes in Joint Disease Therapy].
    Zeng J; Huang S; DU F; Cao S; Gao Y; Qiu L; Tang Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Jul; 55(4):800-806. PubMed ID: 39170029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defect engineering to tailor structure-activity relationship in biodegradable nanozymes for tumor therapy by dual-channel death strategies.
    Su Y; Lv M; Huang Z; An N; Chen Y; Wang H; Li Z; Wu S; Ye F; Shen J; Li A
    J Control Release; 2024 Mar; 367():557-571. PubMed ID: 38301929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Catalase-Like Nanozymes: Classification, Catalytic Mechanisms, and Their Applications.
    Xu D; Wu L; Yao H; Zhao L
    Small; 2022 Sep; 18(37):e2203400. PubMed ID: 35971168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reactive oxygen species-powered cancer immunotherapy: Current status and challenges.
    He M; Wang M; Xu T; Zhang M; Dai H; Wang C; Ding D; Zhong Z
    J Control Release; 2023 Apr; 356():623-648. PubMed ID: 36868519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antioxidant activities of metal single-atom nanozymes in biomedicine.
    Zeng Q; Zhong H; Liao J; Huo Q; Miao B; Zeng L; Zhang B; Nie G
    Biomater Sci; 2024 Oct; 12(20):5150-5163. PubMed ID: 39254215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bidirectional anisotropic palladium nanozymes reprogram macrophages to enhance collaborative chemodynamic therapy of colorectal cancer.
    Chen X; Jia Z; Wen Y; Huang Y; Yuan X; Chen Y; Liu Y; Liu J
    Acta Biomater; 2022 Oct; 151():537-548. PubMed ID: 35981687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prussian Blue: A Nanozyme with Versatile Catalytic Properties.
    Estelrich J; Busquets MA
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34206067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Nanozyme with Photo-Enhanced Dual Enzyme-Like Activities for Deep Pancreatic Cancer Therapy.
    Li S; Shang L; Xu B; Wang S; Gu K; Wu Q; Sun Y; Zhang Q; Yang H; Zhang F; Gu L; Zhang T; Liu H
    Angew Chem Int Ed Engl; 2019 Sep; 58(36):12624-12631. PubMed ID: 31237404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Degradable Tumor-Responsive Iron-Doped Phosphate-Based Glass Nanozyme for H
    Yao Y; Wang Z; Cao Q; Li H; Ge S; Liu J; Sun P; Liu Z; Wu Y; Wang W; Liu J
    ACS Appl Mater Interfaces; 2022 Apr; 14(15):17153-17163. PubMed ID: 35394283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An Fe-based single-atom nanozyme with multi-enzyme activity for parallel catalytic therapy
    Niu R; Liu Y; Wang Y; Zhang H
    Chem Commun (Camb); 2022 Jul; 58(57):7924-7927. PubMed ID: 35762285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.